Covered recipient · General Payments record
ROBERT P GREEN
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2023
$4,124.16
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $291.85 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $166.33 | 5 |
| OptiNose US, Inc. | $38.23 | 2 |
| PFIZER INC. | $23.46 | 1 |
| Merck Sharp & Dohme Corporation | $22.50 | 1 |
| GlaxoSmithKline, LLC. | $21.60 | 1 |
| Kaleo, Inc. | $19.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $35.10 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049672553 | CMS |
| GENZYME CORPORATION | $33.75 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049672577 | CMS |
| GENZYME CORPORATION | $37.93 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049672625 | CMS |
| GENZYME CORPORATION | $29.71 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049672649 | CMS |
| GENZYME CORPORATION | $29.84 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049672673 | CMS |
| GlaxoSmithKline, LLC. | $21.60 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000829031 | CMS |
| kaleo, Inc. | $19.73 | 07/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1013060185 | CMS |
| Merck Sharp & Dohme LLC | $22.50 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048656355 | CMS |
| Optinose US, Inc. | $21.47 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1035156269 | CMS |
| Optinose US, Inc. | $16.76 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1035156413 | CMS |
| PFIZER INC. | $23.46 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050440201 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.